Answers are grounded in this paper and cite their sources.
Case reports detail ineffective enhanced elimination of sodium azide in two fatal cases, suggesting urgent needs. Both patients developed shock and underwent various interventions with limited success.
Ingestion of sodium azide can lead to severe toxicity, including the development of refractory shock. No antidote has been identified. Enhanced elimination has demonstrated variable outcomes in prior reports. We present two fatal cases of sodium azide toxicity. The first patient, a 27-year-old man, ingested approximately 5 g of sodium azide and developed hypotension 1 h after ingestion. Orogastric lavage was performed, and vasopressors were started. Hemodialysis was performed 13 h after ingestion. Despite stabilization, he developed recurrent cardiac arrest and died. The second patient, a 19-year-old man, presented 2 h after the intentional ingestion of 40 mL of 5% (2 g) sodium azide. This patient was started on vasopressors and had plasma exchange performed, after which vasopressor requirements were reduced. Shortly after, however, the patient experienced recrudescence of shock and ultimately succumbed to toxicity. Despite aggressive supportive measures, decompensation refractory to supportive measures occurred in both patients. Enhanced elimination techniques were attempted, albeit not immediately, and the delay in initiating hemodialysis and plasma exchange may have limited any potential benefit. Enhanced elimination did not appear to alter the course of toxicity in these two patients who ingested at least 2 g of sodium azide.
No takes yet. Share an insight, caveat, or question.
Husak et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: